author

 
 

Meta

Suzi Ring
Japan Times
WORLD / Science & Health
May 4, 2023
First RSV vaccine caps 60-year search to stem pervasive lung illness
The U.S. Food and Drug Administration cleared GSK’s shot against respiratory syncytial virus on Wednesday. The product will go on sale in the coming weeks for older adults.
Japan Times
WORLD / Science & Health
May 2, 2023
Bird flu detectives hunt for clues to stop next global pandemic
The speed with which countries can identify and respond to future virus threats will determine how effectively the world can contain the next pandemic.
Japan Times
WORLD / Science & Health
Dec 23, 2021
Omicron brings new risks to mostly unvaccinated pregnant women
About 75% of expectant mothers in the U.K. and about 65% in the U.S. remain unvaccinated, making them among the groups most at risk of getting infected.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Six vaccines show promise as boosters, led by mRNA shots
Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.
Japan Times
WORLD
Oct 11, 2021
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Japan Times
WORLD / Science & Health
Apr 29, 2021
Dark horse of vaccine race may be this French biotech
With the other COVID-19 vaccines in Europe focused on the virus's spike protein, this shot could protect against variants that might compromise others, making it the perfect booster.
Japan Times
WORLD
Mar 24, 2021
AstraZeneca’s pain grows as U.S. questions beleaguered COVID-19 vaccine
U.S. trial data showing the firm's shot to be highly effective was a welcome reprieve this week, but the good news lasted less than a day.
Japan Times
WORLD
Mar 22, 2021
Vaccine battle heats up with EU ready to halt U.K. shipments
Both sides have blamed each other for export curbs and nationalism, posing a risk to the fragile post-Brexit trade relationship agreed on only in December.
Japan Times
WORLD / Science & Health
Feb 14, 2021
Spread of variants sparks push for all-in-one COVID-19 vaccines
Dangerous coronavirus variants are carpeting the globe, pushing scientists in the U.K. and elsewhere to target multiple versions of the pathogen in a single shot.
Japan Times
WORLD
Jan 31, 2021
Faced with a vaccine emergency, the EU made an enemy of everyone
What began as a bid to bring transparency has spiraled into chaotic mud-slinging that some fear could spur a trade row amid the pandemic.
Japan Times
WORLD
Jan 28, 2021
EU fails to sway AstraZeneca to tap U.K. supply for vaccines
The root of the dispute is Astra's decision to prioritize the U.K. over the EU following a Belgian production glitch, in what Brussels claims to be a breach of contractual commitments.
Japan Times
WORLD / Science & Health
Dec 30, 2020
Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval
AstraZeneca PLC and the University of Oxford's Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations.
Japan Times
WORLD / Science & Health
Aug 25, 2020
They beat COVID-19, but debilitating effects and economic costs may linger for years
Long-haulers — survivors of COVID-19 left with debilitating conditions — represent another insidious dimension of the pandemic.

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan